RetinalGenix Technologies (RTGN) Selling, General & Administrative (2021 - 2026)
RetinalGenix Technologies (RTGN) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 349.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -207.22 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 262,149.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,149.00 |
| Dec 31, 2025 | 305,871.00 |
| Sep 30, 2025 | 270,153.00 |
| Jun 30, 2025 | 383,729.00 |
| Mar 31, 2025 | 341,203.00 |
| Dec 31, 2024 | 392,109.00 |
| Sep 30, 2024 | 244,098.00 |
| Jun 30, 2024 | 368,738.00 |
| Mar 31, 2024 | 328,985.00 |
| Dec 31, 2023 | 408,273.00 |
| Sep 30, 2023 | 167,046.00 |
| Jun 30, 2023 | 120,097.00 |
| Mar 31, 2023 | 203,242.00 |
| Dec 31, 2022 | 277,678.00 |
| Sep 30, 2022 | 201,148.00 |
| Jun 30, 2022 | 167,385.00 |
| Mar 31, 2022 | 161,195.00 |
| Dec 31, 2021 | 171,004.00 |
| Sep 30, 2021 | 293,893.00 |
| Jun 30, 2021 | 288,582.00 |